These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25658063)

  • 1. Capsular polysaccharide conformations in pneumococcal serotypes 19F and 19A.
    Kuttel MM; Jackson GE; Mafata M; Ravenscroft N
    Carbohydr Res; 2015 Apr; 406():27-33. PubMed ID: 25658063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative simulation of pneumococcal serogroup 19 polysaccharide repeating units with two carbohydrate force fields.
    Kuttel M; Gordon M; Ravenscroft N
    Carbohydr Res; 2014 May; 390():20-7. PubMed ID: 24681444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Base hydrolysis of phosphodiester bonds in pneumococcal polysaccharides.
    Pujar NS; Huang NF; Daniels CL; Dieter L; Gayton MG; Lee AL
    Biopolymers; 2004 Sep; 75(1):71-84. PubMed ID: 15307199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development.
    Reinert R; Jacobs MR; Kaplan SL
    Vaccine; 2010 Jun; 28(26):4249-59. PubMed ID: 20416266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational analysis of the trisaccharide components of the repeating units of the capsular polysaccharides of Streptococcus pneumoniae types 19F and 19A.
    Ciuffreda P; Colombo D; Ronchetti F; Toma L
    Carbohydr Res; 1992 Aug; 232(2):327-39. PubMed ID: 1423362
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece.
    Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA
    Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the incidence of Streptococcus pneumoniae bacteremia and its serotypes over 10 years in one hospital in South Korea.
    Park M; Kim HS; Shin KS; Kim HS; Park JY; Song W; Cho HC; Lee KM; Kim JS
    Vaccine; 2014 Nov; 32(48):6403-7. PubMed ID: 25305566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.
    Bryant KA; Block SL; Baker SA; Gruber WC; Scott DA;
    Pediatrics; 2010 May; 125(5):866-75. PubMed ID: 20435707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
    Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH
    J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion and evolution of Streptococcus pneumoniae serotype 19A ST320 clone as compared to its ancestral clone, Taiwan19F-14 (ST236).
    Hsieh YC; Lin TL; Chang KY; Huang YC; Chen CJ; Lin TY; Wang JT
    J Infect Dis; 2013 Jul; 208(2):203-10. PubMed ID: 23559465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysaccharide Capsule Composition of Pneumococcal Serotype 19A Subtypes Is Unaltered among Subtypes and Independent of the Nutritional Environment.
    Brugger SD; Troxler LJ; Rüfenacht S; Frey PM; Morand B; Geyer R; Mühlemann K; Höck S; Thormann W; Furrer J; Christen S; Hilty M
    Infect Immun; 2016 Nov; 84(11):3152-3160. PubMed ID: 27550933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility profiles and correlation with pneumococcal serotypes soon after implementation of the 10-valent pneumococcal conjugate vaccine in Brazil.
    Mott M; Caierão J; Rosa da Cunha G; Rodrigues Perez LR; Matusiak R; Pilger de Oliveira KR; d'Azevedo PA; Dias C
    Int J Infect Dis; 2014 Mar; 20():47-51. PubMed ID: 24389158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural elucidation of the capsular polysaccharide from Streptococcus pneumoniae serotype 47A by NMR spectroscopy.
    Petersen BO; Hindsgaul O; Paulsen BS; Redondo AR; Skovsted IC
    Carbohydr Res; 2014 Mar; 386():62-7. PubMed ID: 24486982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.
    Lee MR; Chen CM; Chuang TY; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2013 Nov; 42(5):395-402. PubMed ID: 24071028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
    Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
    Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.